The American Journal of Medicine
Volume 119, Issue 8 , Pages 700-706 , August 2006

Long-Term Prognosis and Causes of Death in Systemic Lupus Erythematosus

  • Andrea Doria, MD

      Affiliations

    • Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Italy
    • Corresponding Author InformationRequests for reprints should be addressed to Andrea Doria, MD, Division of Rheumatology, University of Padova, Via Giustiniani, 2, 35128 PADOVA, Italy
    • ,
  • Luca Iaccarino, MD

      Affiliations

    • Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Italy
    • ,
  • Anna Ghirardello, PhD

      Affiliations

    • Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Italy
    • ,
  • Sandra Zampieri, PhD

      Affiliations

    • Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Italy
    • ,
  • Silvia Arienti, MD

      Affiliations

    • Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Italy
    • ,
  • Piercarlo Sarzi-Puttini, MD

      Affiliations

    • Rheumatology Unit, L Sacco University-Hospital, Milan, Italy
    • ,
  • Fabiola Atzeni, PhD

      Affiliations

    • Rheumatology Unit, L Sacco University-Hospital, Milan, Italy
    • ,
  • Antonio Piccoli, MD

      Affiliations

    • Division of Nephrology, Department of Medical and Surgical Sciences, University of Padova, Italy
    • ,
  • Silvano Todesco, MD

      Affiliations

    • Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Italy

Received 2 August 2005 ,Accepted 29 November 2005.

References 

  1. Merrel M, Shulman LE. Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chronic Dis. 1955;1:12–32
  2. Pistiner M, Wallace DJ, Nessim S, et al. Lupus erythematosus in the 1980s (a survey of 570 patients). Semin Arthritis Rheum. 1991;21:55–64
  3. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period (a comparison of early and late manifestation in a cohort of 1000 patients). Medicine. 2003;82:299–308
  4. Gripenberg M, Helve T. Outcome of systemic lupus erythematosus. A study of 66 patients over 7 years with reference to the predictive value of anti n-DNA antibody determination. Scand J Rheumatol. 1991;20:104–109
  5. Zandman-Goddard G, Shoenfeld Y. SLE and infections. Clin Rev Allergy Immunol. 2003;25:29–40
  6. Kang I, Park SH. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol. 2003;15:528–534
  7. Doria A, Shoenfeld Y, Wu R, et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis. 2003;62:1071–1077
  8. Manger K, Kusus M, ForsterC , et al. Factors associated with coronary artery disease calcification in young female patients with lupus. Ann Rheum Dis. 2003;62:846–850
  9. Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced by corticosteroids therapy. A study of 36 necropsy study. Am J Med. 1975;58:243–263
  10. Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med. 1992;93:513–519
  11. Zonana-Nacach A, Barr SG, Madger LA, Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum. 2000;43:1801–1808
  12. Bernatsky S, Ramsey-Goldman R, Clarke A. Exploring the links between systemic lupus erythematosus and cancer. Rheum Dis Clin North Am. 2005;31:387–402
  13. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis Rheum. 1999;42:1785–1796
  14. Gladman DD, Urowitz MB. Prognosis, mortality and morbidity in systemic lupus erythematosus. In:  Wallace DJ,  Hahn BH editor. Dubois’ Lupus Erythematosus. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2002;p. 1255–1273
  15. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–1277
  16. Vitali C, Bencivelli W, Isenberg DA, et al. The European Consensus Study Group for Disease Activity in SLE Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheumatol. 1992;10:541–547
  17. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum. 1996;39:363–369
  18. Kurata N, Tan EM. Identification of antibodies to nuclear acid antigens by counterimmunoelectrophoresis. Arthritis Rheum. 1976;19:574–580
  19. Bunn CC, Gharavi AE, Hughes GRV. Antibodies to extractable nuclear antigens in 173 patients with DNA binding positive SLE (an association between antibodies to ribonucleoprotein and Sm antigens observed by counterimmunoelectrophoresis). J Clin Lab Immunol. 1982;8:13–17
  20. Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russel Viper Venum Time for the diagnosis of lupus anticoagulants. Blood. 1986;4:869–874
  21. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies (isotype distribution and phospholipid specificity). Ann Rheum Dis. 1987;46:1–6
  22. Dixon WJ, Brown MB, Engelman L, Jennrich RI. BMDP Statistical Software Manual. Berkeley: UCLA; 1990;
  23. Moss KE, Ioannou Y, Sultan SM, et al. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis. 2002;61:409–413
  24. Yeap SS, Chow SK, Manivasagar M, et al. Mortality pattern in Malaysian systemic lupus erythematosus. Med J Malaysia. 2001;56:308–312
  25. Bellomio V, Spindler A, Lucero E, et al. Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study. Lupus. 2000;9:377–381
  26. Alamanos Y, Voulgari PV, Parassava M, et al. Survival and mortality rates of systemic lupus erythematosus patients in northwest Greece. Study of a 21 years incidence cohort. Rheumatology. 2003;42:1122–1123
  27. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single centre. I. Causes of death. J Rheumatol. 1995;22:1259–1264
  28. Blanco FJ, Gomez-Reino JJ, de la Mata J, et al. Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus. 1998;7:159–163
  29. Jacobsen S, Petersen J, Ullman S, et al. Mortality and causes of death in 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol. 1999;28:75–80
  30. Mok CC, Mak A, Chu WP, et al. Long term survival of southern Chinese patients with systemic lupus erythematosus. A prospective study of all age-groups. Medicine. 2005;84:218–224
  31. Urowitz MB, Gladman DD. How to improve morbidity and mortality in systemic lupus erythematosus. Rheumatology. 2000;39:238–244
  32. Bruce IN, Urowitz MB, Gladman DD, et al. Risk factors for coronary heart disease in women with systemic lupus erythematosus (the Toronto risk factor study). Arthritis Rheum. 2003;48:3159–3167
  33. Doria A, Shoenfeld Y, Pauletto P. Premature coronary disease in systemic lupus. N Engl J Med. 2004;350:1571–1575[letter]
  34. Doria A, Sherer Y, Meroni PL, Shoenfeld Y. Inflammation and accelerated atherosclerosis (basic mechanisms). Rheum Dis Clin North Am. 2005;31:355–362
  35. Bernatsky S, Clarke A, Ramsey-Goldman R. Malignancy and systemic lupus erythematosus. Curr Rheumatol Rep. 2002;4:351–358
  36. Abu-Shakra M, Ehrenfeld M, Shoenfeld Y. Systemic lupus erythematosus and cancer (associated or not?). Lupus. 2002;11:137–144
  37. Sandrini S, Setti G, Bossini N, Maiorca P. Cancer after kidney transplantation. G Ital Nefrol. 2004;21(Suppl 26):S67–S73
  38. Bernatsky S, Boivin JF, Joseph L, et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum. 2005;52:1481–1490
  39. Bujàn S, Ordi-Ros J, Paredes J, et al. Contribution of the initial features of systemic lupus erythematosus to the clinical evaluation and survival of a cohort of Mediterranean patients. Ann Rheum Dis. 2003;62:859–865
  40. Kiss E, Regeczy N, Szegedi G. Systemic lupus erythematosus survival in Hungary. Results from a single centre. Clin Exp Rheumatol. 1999;17:171–177
  41. Wallace DJ, Podell T, Weiner J, et al. Systemic lupus erythematosus-survival patterns (experience with 609 patients). JAMA. 1981;245:934–938
  42. Rosner S, Ginzler EM, Diamond HS, et al. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum. 1982;25:612–617

PII: S0002-9343(06)00193-8

doi: 10.1016/j.amjmed.2005.11.034

The American Journal of Medicine
Volume 119, Issue 8 , Pages 700-706 , August 2006

Article Tools

* Image Usage & Resolution